medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number S1

<< Back Next >>

Rev Mex Anest 2013; 36 (S1)

Current affairs in malignant hyperthermia

Carrillo-Esper R, Lázaro-Santiago G, Nava-López JA
Full text How to cite this article

Language: Spanish
References: 18
Page: 307-309
PDF size: 72.34 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Kim D. Malignant hyperthermia. Korean J Anesthesiol. 2012;63:391-401.

  2. Bandschapp O, Girard T. Malignant hyperthermia. Swiss Medical Weekly. 2012;142:1-4.

  3. McCarthy E. Malignant hyperthermia, pathophysiology, clinical presentation and treatment, AACN Clinical Issues. 2004;15:231-237.

  4. Patil P, Pradesh U. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:e1-e7.

  5. Benkusky N, Farrell E, Valdivia H. Ryanodine receptor channelopathies. Biochemical and Biophysical Research Communications. 2004;322:1280-1285.

  6. Denborough M. Malignant hyperthermia. The Lancet. 1998;352:1131-1136.

  7. Rosenberg H, Rueffert H. Clinical utility gene card for: malignant hyperthermia. European Journal of Human Genetics. 2011;19:1-4.

  8. Petegem F. Ryanodine receptors: structure and function. The Journal of Biological Chemistry. 2012;287:31624-31632.

  9. Lanner J, Georgiou D, Joshi A, Hamilton S. Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol. 2010;2:1-21.

  10. Anderson A, Brown R, Polster B, Pollock N, Stowell K. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia. Anesthesiology. 2008;108:208-215.

  11. Correia A, Silva P, Silva B. Hipertermia maligna: aspectos moleculares y clínicos. Rev Bras Anestesiol. 2012;62:1-10.

  12. Benca J, Hogan K. Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options. Anesth Analg. 2009;109:1049-1053.

  13. Hirshey Dirksen SJ, Larach MG, Rosenberg H, Brandom BW, Parness J, Lang RS, et al. Special article: Future directions in malignant hyperthermia research and patient care. Anesth Analg. 2011;113:1108-1119.

  14. Christiansen L, Collins K. Pathologic findings in malignant hypertermia, A case report and review of literature. The American Journal of Forensic Medicine and Pathology. 2004;25:327-333.

  15. Payen de la Garanderie JF, Depret T, Monnier N, Nivoche Y, Lunardi J, Krivosic-Horber R. Hipertermia Maligna. EMC (Elsevier Masson SAS, Paris), Anesthésie-Réanimation. 2004;36-412-E-10.

  16. Elias G, Venegas A. Hipertermia maligna. Acta Pediátrica de Mexico. 1996;17:45-48.

  17. Rosenberg H, Davis M, James D, Pollock N, Stowell K. MalignanT hyperthermia. Orphanet Journal of Rare Diseases. 2007;2:21:1-14.

  18. Wappler F. Anesthesia for patients with a history of malignant hyperthermia. Current Opinion in Anaesthesiology. 2010;23:417-422.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2013;36